Literature DB >> 33710666

RNF8-ubiquitinated KMT5A is required for RNF168-induced H2A ubiquitination in response to DNA damage.

Xiaopeng Lu1, Min Xu1, Qian Zhu1, Jun Zhang1, Ge Liu1, Yantao Bao1, Luo Gu2, Yuan Tian1,3, He Wen1, Wei-Guo Zhu1,3,4.   

Abstract

Histone modifications play critical roles in DNA damage repair to safeguard genome integrity. However, how different histone modifiers coordinate to build appropriate chromatin context for DNA damage repair is largely unknown. Here, we report a novel interplay between the histone methyltransferase KMT5A and two E3 ligases RNF8 and RNF168 in establishing the histone modification status for DNA damage repair. KMT5A is a newly identified substrate of RNF8 in vitro and in vivo. In response to DNA double-strand breaks (DSBs), RNF8 promotes KMT5A recruitment onto damaged chromatin in a ubiquitination-dependent manner. RNF8-induced KMT5A ubiquitination increases the binding capacity of KMT5A to RNF168. Interestingly, KMT5A not only drives a local increase in H4K20 monomethylation at DSBs, but also promotes RNF168's activity in catalyzing H2A ubiquitination. We proved that the interaction between the H2A acidic patch and KMT5A R188/R189 residues is critical for KMT5A-mediated regulation of H2A ubiquitination. Taken together, our results highlight a new role for KMT5A in linking H4K20 methylation and H2A ubiquitination and provide insight into the histone modification network during DNA damage repair.
© 2021 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  DNA double-strand breaks; KMT5A; RNF168; RNF8; histone ubiquitination

Year:  2021        PMID: 33710666     DOI: 10.1096/fj.202002234R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  1 in total

Review 1.  Roles for the methyltransferase SETD8 in DNA damage repair.

Authors:  Libo Xu; Ling Zhang; Jicheng Sun; Xindan Hu; Dhan V Kalvakolanu; Hui Ren; Baofeng Guo
Journal:  Clin Epigenetics       Date:  2022-03-04       Impact factor: 6.551

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.